Skip to content

Shared Decision Making in Low Risk Prostate Cancer

Shared Decision Making: A Study Assessing the Benefit of a Web Based Aid Presenting Treatment Options for Patients With Low Risk Prostate Cancer

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01673581
Enrollment
0
Registered
2012-08-28
Start date
2012-08-01
Completion date
2020-06-05
Last updated
2026-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Keywords

Low Risk

Brief summary

This study will evaluate the usefulness of an informational website designed to educate patients with prostate cancer about their options for treatment. The investigators hope that this website will assist patients with making informed decisions about their care and improving their satisfaction with the treatments they choose.

Detailed description

Investigators will first ask patients to answer a series of questions to assess their wishes regarding treatment, knowledge about their disease and discussion with the physicians at initial patient visit. This initial survey should take approximately 20 minutes. Once patients have selected a treatment path investigators will contact them again and ask them to fill out a short 10-minute survey online or by mail. Investigators will contact patients by phone 2 weeks after their initial visit to see if they have made a decision. If not, investigators will contact patients by phone every 2 weeks or at an interval that works for the patient's schedule. Finally, 3 months after the initial visit today investigators will contact patients for the last time and again ask you to fill out a short 10-minute survey online or by mail. Once patients have completed the final survey there are no future surveys planned. Investigators may contact patients by phone in the future to ask them to participate in another study.

Interventions

OTHERSurvey

Sponsors

Massachusetts General Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Histologically confirmed prostate adenocarcinoma * Internet access * Able to read and understand English

Exclusion criteria

* Evidence of nodal metastases * Evidence of distant metastases * Prior surgery, chemotherapy, pelvic radiation or prostate brachytherapy for prostate cancer

Design outcomes

Primary

MeasureTime frameDescription
Patient knowledge regarding the available treatment options for low-risk prostate cancer and their potential side effects.2 yearsInvestigators will assess the impact of an informational website developed specifically to assist low-risk prostate cancer patients with knowledge of their disease and treatment options. This will be measured by patient responses to questionnaires compiled from validated sources.

Secondary

MeasureTime frameDescription
Decisional conflict and informed decision making experienced by patients.2 yearsInvestigators will assess the impact of an informational website developed specifically to assist low-risk prostate cancer patients with knowledge of their disease and treatment options. This will be measured by patient responses to questionnaires compiled from validated sources.
Patient health related worry.2 yearsInvestigators will assess the impact of an informational website developed specifically to assist low-risk prostate cancer patients with knowledge of their disease and treatment options. This will be measured by patient responses to questionnaires compiled from validated sources.
Patient views on cancer control for their treatment choice.2 yearsInvestigators will assess the impact of an informational website developed specifically to assist low-risk prostate cancer patients with knowledge of their disease and treatment options. This will be measured by patient responses to questionnaires compiled from validated sources.
Patient satisfaction with their treatment choice.2 yearsInvestigators will assess the impact of an informational website developed specifically to assist low-risk prostate cancer patients with knowledge of their disease and treatment options. This will be measured by patient responses to questionnaires compiled from validated sources.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORJason A. Efstathiou, MD, DPhil

Massachusetts General Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 16, 2026